ログイン

HTMLE

HTMLE
44問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    What is the national reference laboratory designed for infectious diseases, except for STIs? a. RITM b. NKTI c. EAMC d. SLH

    a. RITM

  • 2

    What is the national reference laboratory for water testing? a. RITM b. EAMC c. NKTI d. LCP

    b. EAMC

  • 3

    All of the following are nonformal learning, except: a. Educational lectures b. On the job training c. Seminar d. Social media vlog

    d. Social media vlog

  • 4

    The filing for Medical Technology Licensure Examination opens ____ before the scheduled licensure examination. a. One month b. Two months c. Three months d. Four months

    c. Three months

  • 5

    All of the following are screened in the expanded newborn screening program, except: a. G6PD defiency b. Neonatal diabetes c. Congenital adrenal hyperplasia d. Congenital hypothyroidism (cretinism)

    b. Neonatal diabetes

  • 6

    The general average needed to pass the board examination must be at least: a. 60% b. 70% c. 75% d. 80%

    c. 75%

  • 7

    All are roles of a medical technologists, EXCEPT: a. Collection of specimen b. Clinical research involving human beings c. Preparation and standardization of reagents d. Diagnosis of diseases

    d. Diagnosis of diseases

  • 8

    All are violations of RA 5527, except: a. Refusal to display COR inside the laboratory b. Using expired or invalid COR c. Release of fraudulent result d. Refusal to identify gender identity

    d. Refusal to identify gender identity

  • 9

    Which of the following specimens are used for drug testing? (I) Blood (II) Saliva (III) Hair (IV) Semen a. I and III b. I, II, and III c. I, II, III, and IV d. I only

    b. I, II, and III

  • 10

    Which of the following is a conflict of interest? a. Promotion of proper handwashing to the community during a speech. b. Payment of fees to laboratory works performed by medical technologist. c. Guest speaker promotes his company products to his colleagues during a seminar. d. None of the above

    c. Guest speaker promotes his company products to his colleagues during a seminar

  • 11

    Which of the following is the correct list of principles of ethics? a. Beneficence, justice, confidentiality, and autonomy b. Beneficence, justice, autonomy, and nonmaleficence c. Confidentiality, beneficence, non-maleficence, and autonomy. d. Beneficence, confidentiality, non-maleficence, and justice.

    b. Beneficence, justice, autonomy, and nonmaleficence

  • 12

    Where does acknowledgement page go in a research paper? a. After title page b. Table of contents c. Bibliography d. Reference

    a. After title page

  • 13

    Validity of drug test result: a. 6 months b. 1 year c. 2 years d. 3 years

    b. 1 year

  • 14

    Which of the following describes an electronic signature? a. Signature different to the signature of a person on a written document. b. Signature equivalent to the signature of a person on a written document. c. Signature alternative to the signature of a person on a written document. d. A simplified signature of a longer signature.

    b. Signature equivalent to the signature of a person on a written document.

  • 15

    How to maintain confidentiality? a. Password protected device b. Posting of LIS password at post c. Never changing one’s password d. Encryption of data

    d. Encryption of data

  • 16

    What is the best way to communicate patient result to provider? a. Via telephone b. Verbal reporting c. Writing d. Electronic

    d. Electronic

  • 17

    New curriculum of BSMT/BMLS involves how many months of internship programs? a. 3 months b. 6 months c. 12 months d. 16 months

    c. 12 months

  • 18

    Under RA 7170 or “Organ Donation Act of 1991,” an individual who makes a legacy of all or part of his body refers to: a. Decedent b. Testator c. Donor d. None of the above

    b. Testator

  • 19

    Which of the following person may execute donation of all or any part of a decedent’s body? (I) Spouse (II) Son or daughter of legal age (III) Friend a. I and II b. II and III c. I and III d. I, II, and III

    a. I and II

  • 20

    Which of the following is an example of classification as to duration of the disease? a. Mild and severe b. Acute and chronic c. Benign and malignant d. Contagious and non-contagious

    b. Acute and chronic

  • 21

    Which of the following changes are autonomous in nature? a. Metaplasia b. Dysplasia c. Aplasia d. Neoplasia

    d. Neoplasia

  • 22

    Which of the following wounds is caused by friction against a rough surface? a. Abrasion b. Contusion c. Laceration d. Hematoma

    a. Abrasion

  • 23

    All of the following are closed wound, except: a. Hematoma b. Crush injuries c. Contusion d. Puncture

    d. Puncture

  • 24

    Stain in PAP smear that has affinity for keratin: a. Eosin Azure 50 b. Orange Green 6 c. Hematoxylin d. None of the above

    b. Orange Green 6

  • 25

    Using Pap’s stain, which of the following has no effect on the staining pattern and color (does not stain anything)? a. OG6 b. EA50 c. Light green SF d. Bismarck brown Y

    d. Bismarck brown Y

  • 26

    Bismarck brown Y if added to the Pap’s stain formula will: a. Stain keratinized cells orange b. Act as a mordant c. Precipitate phosphotungstic acid d. None of the above

    c. Precipitate phosphotungstic acid

  • 27

    This is used as an alternative for 95% ethanol in Pap’s staining, EXCEPT: a. Distilled water b. Corn syrup c. Absolute alcohol d. Hair spray

    a. Distilled water

  • 28

    All of the following describes a mordant, except: a. It is a dye fixative b. It intensifies the stain c. It is a metal d. It is a nonmetal

    d. It is a nonmetal

  • 29

    Ripening of hematoxylin is a process of: a. Oxidation b. Reduction c. Oxidation then reduction d. Reduction then oxidation

    a. Oxidation

  • 30

    All of the following are physical methods of fixation, except: a. Microwave b. Heat c. Freeze drying d. Vapor

    d. Vapor

  • 31

    All of the following are composition of Bouin’s fluid, EXCEPT: a. Ethanol b. Saturated picric acid c. Formalin/formaldehyde d. Glacial acetic acid

    a. Ethanol

  • 32

    Formaldehyde fixation is performed at: a. 28 C b. 4 C c. Room temperature d. Ambient temperature

    c. Room temperature

  • 33

    All of the following can be carried out by using a microwave, except: a. Staining b. Decalcification c. Fixation d. Embedding

    d. Embedding

  • 34

    Which of the following used as a preservative for formaldehyde? a. 10% methanol b. 70% ethanol c. Phenol d. Thymol crystals

    a. 10% methanol

  • 35

    Transition between dehydration and infiltration of embedding medium: a. Clearing b. Impregnation c. Rehydration d. Dehydration

    a. Clearing

  • 36

    Clearing agent should have: a. Low refractive index b. High refractive index c. Neutral refractive index d. None of the above

    b. High refractive index

  • 37

    Which of the following is miscible in paraffin? a. Distilled water b. Ethyl alcohol c. Xylene d. Alcohol

    c. Xylene

  • 38

    In IHC, enzyme label is reacted with a substrate to yield an/a: a. White product b. Colorless product c. Black product d. Intensely colored product

    d. Intensely colored product

  • 39

    Irreversible change: a. Dysplasia b. Metaplasia c. Neoplasia d. Hyperplasia

    c. Neoplasia

  • 40

    Which of the following is a stain for glycogen and mucopolysaccharides? a. Gram stain b. Periodic acid Schiff c. Perl’s Prussian blue stain d. Bielschowsky’s technique

    b. Periodic acid Schiff

  • 41

    What is the purpose of water bath? a. To make tissue more presentable b. To enhance the affinity of stain to tissue c. To remove wrinkles d. To flatten tissue

    d. To flatten tissue

  • 42

    Which of the following is breast cancer marker? a. CA 19-9 b. NMP c. CA 125 d. Her2/Neu

    d. Her2/Neu

  • 43

    The first and most important step in operation of any piece of equipment is to: a. Read the manual b. Identify the cost of the test c. Ask the chief medtech d. Try it out!

    a. Read the manual

  • 44

    How many changes of paraffin is done in Autotechnicon? a. One b. Two c. Three d. Four

    b. Two

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    What is the national reference laboratory designed for infectious diseases, except for STIs? a. RITM b. NKTI c. EAMC d. SLH

    a. RITM

  • 2

    What is the national reference laboratory for water testing? a. RITM b. EAMC c. NKTI d. LCP

    b. EAMC

  • 3

    All of the following are nonformal learning, except: a. Educational lectures b. On the job training c. Seminar d. Social media vlog

    d. Social media vlog

  • 4

    The filing for Medical Technology Licensure Examination opens ____ before the scheduled licensure examination. a. One month b. Two months c. Three months d. Four months

    c. Three months

  • 5

    All of the following are screened in the expanded newborn screening program, except: a. G6PD defiency b. Neonatal diabetes c. Congenital adrenal hyperplasia d. Congenital hypothyroidism (cretinism)

    b. Neonatal diabetes

  • 6

    The general average needed to pass the board examination must be at least: a. 60% b. 70% c. 75% d. 80%

    c. 75%

  • 7

    All are roles of a medical technologists, EXCEPT: a. Collection of specimen b. Clinical research involving human beings c. Preparation and standardization of reagents d. Diagnosis of diseases

    d. Diagnosis of diseases

  • 8

    All are violations of RA 5527, except: a. Refusal to display COR inside the laboratory b. Using expired or invalid COR c. Release of fraudulent result d. Refusal to identify gender identity

    d. Refusal to identify gender identity

  • 9

    Which of the following specimens are used for drug testing? (I) Blood (II) Saliva (III) Hair (IV) Semen a. I and III b. I, II, and III c. I, II, III, and IV d. I only

    b. I, II, and III

  • 10

    Which of the following is a conflict of interest? a. Promotion of proper handwashing to the community during a speech. b. Payment of fees to laboratory works performed by medical technologist. c. Guest speaker promotes his company products to his colleagues during a seminar. d. None of the above

    c. Guest speaker promotes his company products to his colleagues during a seminar

  • 11

    Which of the following is the correct list of principles of ethics? a. Beneficence, justice, confidentiality, and autonomy b. Beneficence, justice, autonomy, and nonmaleficence c. Confidentiality, beneficence, non-maleficence, and autonomy. d. Beneficence, confidentiality, non-maleficence, and justice.

    b. Beneficence, justice, autonomy, and nonmaleficence

  • 12

    Where does acknowledgement page go in a research paper? a. After title page b. Table of contents c. Bibliography d. Reference

    a. After title page

  • 13

    Validity of drug test result: a. 6 months b. 1 year c. 2 years d. 3 years

    b. 1 year

  • 14

    Which of the following describes an electronic signature? a. Signature different to the signature of a person on a written document. b. Signature equivalent to the signature of a person on a written document. c. Signature alternative to the signature of a person on a written document. d. A simplified signature of a longer signature.

    b. Signature equivalent to the signature of a person on a written document.

  • 15

    How to maintain confidentiality? a. Password protected device b. Posting of LIS password at post c. Never changing one’s password d. Encryption of data

    d. Encryption of data

  • 16

    What is the best way to communicate patient result to provider? a. Via telephone b. Verbal reporting c. Writing d. Electronic

    d. Electronic

  • 17

    New curriculum of BSMT/BMLS involves how many months of internship programs? a. 3 months b. 6 months c. 12 months d. 16 months

    c. 12 months

  • 18

    Under RA 7170 or “Organ Donation Act of 1991,” an individual who makes a legacy of all or part of his body refers to: a. Decedent b. Testator c. Donor d. None of the above

    b. Testator

  • 19

    Which of the following person may execute donation of all or any part of a decedent’s body? (I) Spouse (II) Son or daughter of legal age (III) Friend a. I and II b. II and III c. I and III d. I, II, and III

    a. I and II

  • 20

    Which of the following is an example of classification as to duration of the disease? a. Mild and severe b. Acute and chronic c. Benign and malignant d. Contagious and non-contagious

    b. Acute and chronic

  • 21

    Which of the following changes are autonomous in nature? a. Metaplasia b. Dysplasia c. Aplasia d. Neoplasia

    d. Neoplasia

  • 22

    Which of the following wounds is caused by friction against a rough surface? a. Abrasion b. Contusion c. Laceration d. Hematoma

    a. Abrasion

  • 23

    All of the following are closed wound, except: a. Hematoma b. Crush injuries c. Contusion d. Puncture

    d. Puncture

  • 24

    Stain in PAP smear that has affinity for keratin: a. Eosin Azure 50 b. Orange Green 6 c. Hematoxylin d. None of the above

    b. Orange Green 6

  • 25

    Using Pap’s stain, which of the following has no effect on the staining pattern and color (does not stain anything)? a. OG6 b. EA50 c. Light green SF d. Bismarck brown Y

    d. Bismarck brown Y

  • 26

    Bismarck brown Y if added to the Pap’s stain formula will: a. Stain keratinized cells orange b. Act as a mordant c. Precipitate phosphotungstic acid d. None of the above

    c. Precipitate phosphotungstic acid

  • 27

    This is used as an alternative for 95% ethanol in Pap’s staining, EXCEPT: a. Distilled water b. Corn syrup c. Absolute alcohol d. Hair spray

    a. Distilled water

  • 28

    All of the following describes a mordant, except: a. It is a dye fixative b. It intensifies the stain c. It is a metal d. It is a nonmetal

    d. It is a nonmetal

  • 29

    Ripening of hematoxylin is a process of: a. Oxidation b. Reduction c. Oxidation then reduction d. Reduction then oxidation

    a. Oxidation

  • 30

    All of the following are physical methods of fixation, except: a. Microwave b. Heat c. Freeze drying d. Vapor

    d. Vapor

  • 31

    All of the following are composition of Bouin’s fluid, EXCEPT: a. Ethanol b. Saturated picric acid c. Formalin/formaldehyde d. Glacial acetic acid

    a. Ethanol

  • 32

    Formaldehyde fixation is performed at: a. 28 C b. 4 C c. Room temperature d. Ambient temperature

    c. Room temperature

  • 33

    All of the following can be carried out by using a microwave, except: a. Staining b. Decalcification c. Fixation d. Embedding

    d. Embedding

  • 34

    Which of the following used as a preservative for formaldehyde? a. 10% methanol b. 70% ethanol c. Phenol d. Thymol crystals

    a. 10% methanol

  • 35

    Transition between dehydration and infiltration of embedding medium: a. Clearing b. Impregnation c. Rehydration d. Dehydration

    a. Clearing

  • 36

    Clearing agent should have: a. Low refractive index b. High refractive index c. Neutral refractive index d. None of the above

    b. High refractive index

  • 37

    Which of the following is miscible in paraffin? a. Distilled water b. Ethyl alcohol c. Xylene d. Alcohol

    c. Xylene

  • 38

    In IHC, enzyme label is reacted with a substrate to yield an/a: a. White product b. Colorless product c. Black product d. Intensely colored product

    d. Intensely colored product

  • 39

    Irreversible change: a. Dysplasia b. Metaplasia c. Neoplasia d. Hyperplasia

    c. Neoplasia

  • 40

    Which of the following is a stain for glycogen and mucopolysaccharides? a. Gram stain b. Periodic acid Schiff c. Perl’s Prussian blue stain d. Bielschowsky’s technique

    b. Periodic acid Schiff

  • 41

    What is the purpose of water bath? a. To make tissue more presentable b. To enhance the affinity of stain to tissue c. To remove wrinkles d. To flatten tissue

    d. To flatten tissue

  • 42

    Which of the following is breast cancer marker? a. CA 19-9 b. NMP c. CA 125 d. Her2/Neu

    d. Her2/Neu

  • 43

    The first and most important step in operation of any piece of equipment is to: a. Read the manual b. Identify the cost of the test c. Ask the chief medtech d. Try it out!

    a. Read the manual

  • 44

    How many changes of paraffin is done in Autotechnicon? a. One b. Two c. Three d. Four

    b. Two